Research Article
Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
Table 1
Clinical characteristics of the study population.
| | Clinical characteristics | Non-PDR | PDR | value
Non-PDR versus PDR | | MH | ERM |
| | Age (Y) | | | | | | Median (range) | 59 (47–70) | 56 (41–69) | 58 (46–73) | | | Gender | | | | | | Female | 8 (50%) | 6 (60%) | 14 (44%) | | | Male | 8 (50%) | 4 (40%) | 18 (56%) | | | Duration of Diabetic (Y) | | | | | | Median (range) | — | — | 10 (5–14) | — | | Fasting blood-glucose (mmol/L) | | | | | | Median (range) | 4.84 (4.08–6.00) | 5.09 (4.56–6) | 7.35 (4.34–8.92) | | | Glycosylated hemoglobin (%) | 5.35 (4.78–5.8) | 5.05 (4.67–6.0) | 7.0 (4.7–9.6) | | | Received insulin treatment | — | — | 29 (90.6%) | — | | Received photocoagulation treatment | — | — | 28 (87.5%) | — |
|
|
value was calculated by Mann-Whitney test or chi-square test between non-PDR and PDR cases.
|
